Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021902 · ClinicalTrials.gov registry record · Phase 2
Nutrition and Exercise in Critical Illness
A Phase 2 study, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 115
- Enrollment target
NCT03021902: Completed Phase 2 study, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
NCT03021902 is a Phase 2 study that has completed, run by Clinical Evaluation Research Unit at Kingston General Hospital. The registered enrollment target is 115 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03021902, a Phase 2 study, has completed, sponsored by Clinical Evaluation Research Unit at Kingston General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 115 participants
- Enrollment target
Study Summary
This study proposes a novel early intervention combining Intravenous (IV) amino acids plus in-bed cycle ergometry exercise to improve physical outcomes in critically ill patients. The investigators hypothesize that this innovative approach will improve short-term physical functioning outcomes (primary outcome), as well as amino acid metabolism, body composition, and patient-reported outcomes at 6-month follow-up.
Primary Outcome
6-minute walk distance
Interventions
- DRUG IV amino acids
- DEVICE In-bed cycle ergometry exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2025-06-23 |
| Phase | Phase 2 |
What the finished NCT03021902 record still lists
NCT03021902 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 2 interventions - of which IV amino acids is the first listed.
NCT03021902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03021902 about?
NCT03021902 is a clinical study titled "Nutrition and Exercise in Critical Illness". This study proposes a novel early intervention combining Intravenous (IV) amino acids plus in-bed cycle ergometry exercise to improve physical outcomes in critically ill patients. The investigators hypothesize that this innovative approach will improve short-term physical functioning outcomes (prima...
What is the current status of trial NCT03021902?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 2017-09-28. Estimated completion is 2025-06-23.
What interventions are being tested in trial NCT03021902?
The interventions under investigation include: IV amino acids (DRUG), In-bed cycle ergometry exercise (DEVICE).
Who is sponsoring clinical trial NCT03021902?
This trial is sponsored by Clinical Evaluation Research Unit at Kingston General Hospital, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03021902's enrollment target sits among peer trials
115 626th of 2000 higher than 1,374 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI